Intracellular anti-E7 human antibodies in single-chain format inhibit proliferation of HPV16-positive cervical carcinoma cells

被引:20
作者
Accardi, L [1 ]
Donà, MG [1 ]
Di Bonito, P [1 ]
Giorgi, C [1 ]
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy
关键词
human papillomavirus; E7; protein; intrabodies; single chain variable fragment; antiproliferative effect; cervical cancer;
D O I
10.1002/ijc.21052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The E7 tumor antigen of human papillomavirus type 16 (HPV16) is a validated target for immunodiagnosis and immunotherapy of HPV-associated cervical cancer. Anti-HPV16 E7 antibodies in scFv format were isolated from a human antibody phage display library and characterized. With the aim of interfering with the oncogenic activity of E7 protein, the most reactive of the selected antibody fragments was expressed by eukaryotic vectors in different compartments of the HPV16-positive cervical carcinoma SiHa cell line. The intracellular antibodies (intrabodies) were tested for their ability of inhibiting cell proliferation. A significant inhibition was obtained targeting the intrabodies to the nuclear and secretory compartments whereas no significant effect was observed in case of cytoplasmic localization. Inhibition was highly specific as no antiproliferative effect was obtained either with the E7-specific intrabodies in HPV-negative cells nor with irrelevant intrabodies in SiHa cells. (c) 2005 Wiley-Liss. hic.
引用
收藏
页码:564 / 570
页数:7
相关论文
共 35 条
[1]   Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target [J].
Arafat, W ;
Gómez-Navarro, J ;
Xiang, JL ;
Siegal, GP ;
Alvarez, RD ;
Curiel, DT .
CANCER GENE THERAPY, 2000, 7 (09) :1250-1256
[2]   Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo [J].
Balsitis, SJ ;
Sage, J ;
Duensing, S ;
Münger, K ;
Jacks, T ;
Lambert, PF .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (24) :9094-9103
[3]   Genetically engineered intracellular single-chain antibodies in gene therapy [J].
Bilbao, G ;
Contreras, JL ;
Curiel, DT .
MOLECULAR BIOTECHNOLOGY, 2002, 22 (02) :191-211
[4]   EXPRESSION AND TARGETING OF INTRACELLULAR ANTIBODIES IN MAMMALIAN-CELLS [J].
BIOCCA, S ;
NEUBERGER, MS ;
CATTANEO, A .
EMBO JOURNAL, 1990, 9 (01) :101-108
[5]   REDOX STATE OF SINGLE-CHAIN FV FRAGMENTS TARGETED TO THE ENDOPLASMIC-RETICULUM, CYTOSOL AND MITOCHONDRIA [J].
BIOCCA, S ;
RUBERTI, F ;
TAFANI, M ;
PIERANDREIAMALDI, P ;
CATTANEO, A .
BIO-TECHNOLOGY, 1995, 13 (10) :1110-1115
[6]  
Cardinale A, 2001, EUR J BIOCHEM, V268, P268, DOI 10.1046/j.1432-1033.2001.01876.x
[7]   The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells [J].
Cardinale, A ;
Lener, M ;
Messina, S ;
Cattaneo, A ;
Biocca, S .
FEBS LETTERS, 1998, 439 (03) :197-202
[8]  
CATANEO A, 1997, INTRACELLULAR ANTIBO, P105
[9]  
Chames Patrick, 2002, Methods Mol Biol, V178, P147
[10]   Antibody humanization: a case of the 'Emperor's new clothes'? [J].
Clark, M .
IMMUNOLOGY TODAY, 2000, 21 (08) :397-402